Global Cancer Immunotherapy
Market Report
2025
Cancer Immunotherapy Market Report 2025 (Global Edition)
The Global Cancer Immunotherapy Market was valued at USD 128.74 Billion in 2023 and is projected to reach USD 238.38 Billion by 2030, registering a CAGR of 9.2% for the forecast period 2024-2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Cancer Immunotherapy Market Report 2024.
Global Cancer Immunotherapy Market Report 2024 Market Size Split by Product (Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines), by Application (Lung Cancer, Breast ...
The global Cancer Immunotherapy Market was valued at USD 128.74 Billion in 2023 and is projected to reach USD 238.38 Billion by 2030, registering a CAGR of 9.2% for the forecast period 2024-2030.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Cancer Immunotherapy Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.2% |
| Market Split by Product |
|
| Market Split by Application |
|
| Market Split by End-Use |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Cancer Immunotherapy industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Cancer Immunotherapy Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Cancer Immunotherapy Market Report Description
What is Cancer immunotherapy?
Cancer immunotherapy is a type of cancer treatment that harnesses the body's own immune system to identify, target, and destroy cancer cells. The immune system plays a crucial role in protecting the body against infections and abnormal cells, including cancer cells. However, cancer cells can sometimes evade the immune system's detection or suppress its activity, allowing tumors to grow and spread.
Cancer Immunotherapy Market Size
The key driving factors for the Cancer Immunotherapy Market
- The surging worldwide incidence of cancer, coupled with significant investments in the research and development of groundbreaking oncology therapies eventually drives the cancer immunotherapy market growth.
The global population continues to grow, and as people age, the risk of developing cancer increases. With more people living longer, there is a higher prevalence of cancer diagnoses. Modern lifestyles characterized by poor dietary habits, lack of physical activity, and increased exposure to environmental carcinogens have contributed to the rising incidence of cancer. Advances in medical imaging and diagnostic technologies have led to earlier and more accurate cancer detection, leading to an increase in reported cases. The use of tobacco and alcohol, known carcinogens, remains a significant contributor to cancer incidence, particularly in lung, liver, and oral cancers.
- For instance, the Parker Institute for Cancer Immunotherapy has forged partnerships with researchers and industry experts to pioneer revolutionary immune-based cancer therapies. According to data from the Global Cancer Observatory, the United States recorded approximately 2,281,658 cancer diagnoses and 612,390 cancer-related fatalities in 2020. The prevalent malignancies impacting the U.S. populace encompass breast, prostate, lung, and colorectal cancers.
- For instance, data from the Cancer Council reveals that Australia documented 150,000 new cancer diagnoses and 50,000 cancer-related fatalities in 2020. Consequently, the notable increase in the incidence of cancer cases is expected to propel market growth in the foreseeable future.
- For instance, the Cancer Research Institute has provided funding for over 120 clinical trials and has allocated approximately USD 474 million towards research endeavors. Additionally, the Society for Immunotherapy of Cancer (SITC) is actively committed to enhancing patient outcomes by advancing the field of oncology immunotherapy. These organizations collaborate closely with scientists and researchers to explore innovative immune therapy treatment approaches.
- For instance, In June 2022, a team of researchers at Stanford University secured a grant of USD 13 million from Cancer Grand Challenges, an initiative jointly supported by Cancer Research UK and the U.S. National Cancer Institute. This financial support has been granted to advance the development of cutting-edge immunotherapies, explore extrachromosomal DNA, and delve into the study of early-stage cancer
Expanding indications & personalized medicines significantly boost the cancer immunotherapy market growth.
Immunotherapies are being explored for a wide range of cancer types, including melanoma, lung cancer, bladder cancer, breast cancer, and more. As research uncovers new targets and mechanisms, the potential applications of immunotherapy continue to expand. Advances in understanding the genetic and molecular characteristics of tumors have led to the development of personalized immunotherapies. Tailoring treatments to an individual's unique tumor profile can improve response rates and reduce side effects. Thus, expanding indications & personalized medicines eventually boost the cancer immunotherapy market growth.
The Restraining Factor of Cancer Immunotherapy Market
-
Autoimmune reactions & skin reactions may restrain the cancer immunotherapy market growth.
Immunotherapies can trigger autoimmune reactions where the immune system mistakenly targets and damages normal cells or tissues, leading to conditions such as colitis, hepatitis, thyroiditis, and pneumonitis. Rashes, itching, and more severe skin conditions like dermatitis and bullous pemphigoid can occur as a result of immunotherapy. These several factors may hamper the cancer immunotherapy market growth.
Impact of the COVID-19 Pandemic on the Cancer Immunotherapy Market
Clinical trials are essential for testing the safety and efficacy of new cancer immunotherapies. The pandemic disrupted many clinical trials, leading to delays in drug development and regulatory approvals. These delays have affected the introduction of new treatments to the market. Shifts in Healthcare Resources: Healthcare resources, including medical personnel and facilities, were diverted to address the pandemic's immediate needs. This diversion had an impact on the availability of resources for cancer patients, potentially delaying or interrupting cancer treatments. Cancer patients, particularly those with compromised immune systems due to treatment, faced heightened concerns about the risk of COVID-19 infection. Some patients postponed or modified their cancer treatment plans, affecting the demand for cancer immunotherapies.
We have various report editions of Cancer Immunotherapy Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Cancer Immunotherapy Market Insights Video
Cancer Immunotherapy Industry News:
In November 2020, Sanofi, a pharmaceutical company, announced the acquisition of Kiadis Pharma, a pharmaceutical company specializing in cell-based immunotherapy products to treat cancer. The acquisition will give Sanofi access to Kiadis’ K-NK-cell platform, which is intended to make products rapidly and economically available for a broad patient population across a wide range of indications. This will strengthen Sanofi’s product portfolio.
Top Companies Market Share in Cancer Immunotherapy Industry: (In no particular order of Rank)
- Pfizer Inc.
- AstraZeneca
- Merck & Co. Inc
- F. Hoffmann-La Roche Ltd
- Bristol-Myers Squibb Company
- Novartis AG
- Lilly
- Johnson & Johnson Services
- Inc.; Immunocore Ltd.
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
North America cancer immunotherapy accounted for the largest revenue share in 2023
In 2023 North America region dominated the largest market share of 45.32% throughout the forecast period. The North America regional market is experiencing growth due to the significant presence of prominent players and their various strategic initiatives. Additionally, the rising prevalence of diseases, alongside the support provided by government and non-government organizations to promote cancer immunotherapy research, as well as the increasing approvals of innovative drugs, are all contributing to the expansion of the market.
- For instance, in April 2022, the U.S. Food and Drug Administration (FDA) granted approval for Opdivo (nivolumab) as a treatment option for adult patients with non-small cell lung cancer (NSCLC).
The current report Scope analyzes Cancer Immunotherapy Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Cancer Immunotherapy Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Cancer Immunotherapy Market Analysis
Global Cancer Immunotherapy Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Cancer Immunotherapy Industry growth. Cancer Immunotherapy market has been segmented with the help of its Product, Application End-Use, and others. Cancer Immunotherapy market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
In 2023, the monoclonal antibodies segment accounted for the largest market share in the cancer immunotherapy market
Based on the product, the monoclonal antibodies segment dominated the largest market share throughout the forecast period. Monoclonal antibodies in cancer immunotherapy refer to laboratory-produced molecules specifically designed to target and treat cancer. These monoclonal antibodies are engineered to recognize and bind to specific antigens or proteins present on the surface of cancer cells or within the tumor microenvironment.
The expansion of the monoclonal antibodies segment can be attributed to several factors, including the widespread prescription of monoclonal antibodies, their precise targeting capabilities, the relatively lower incidence of side effects, and the robust commercial success and sales performance of prominent monoclonal antibodies such as Keytruda, Yervoy, and Opdivo.
For instance, in Q1 2022, Bristol-Myers Squibb Company saw a 5% rise in revenue for Opdivo and Yervoy compared to the same period in 2021.
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
Cancer Immunotherapy Market Share (%) by Product in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Cancer Immunotherapy Industry. Request a Free Sample PDF!
By Application, the Breast Cancer segment has the largest revenue share of Breast Cancer market!
The breast cancer segment has the largest revenue share of the global market, due to the increasing prevalence of breast cancer across the globe.
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Others
Cancer Immunotherapy Market Share (%) by Application in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Cancer Immunotherapy End-Use Segment Analysis
By end user, hospitals have the largest revenue share of the cancer immunotherapy market, due to the extensive use of cancer immunotherapy in hospitals.
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Author's Detail
Manjiri KanhereSenior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Cancer Immunotherapy Market is witnessing significant growth in the near future.
In 2023, the Monoclonal Antibodies segment accounted for noticeable share of global Cancer Immunotherapy Market and is projected to experience significant growth in the near future.
The Lung Cancer segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Pfizer Inc. , Merck & Co. Inc and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions (FAQs)
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Cancer Immunotherapy Market
Sources from Pharma & Healthcare Industry
- https://en.wikipedia.org/wiki/American_Society_for_Pharmacy_Law
- https://en.wikipedia.org/wiki/American_Society_of_Consultant_Pharmacists
- https://en.wikipedia.org/wiki/American_Society_of_Health-System_Pharmacists
- https://www.apsm-uk.com/
- https://en.wikipedia.org/wiki/Australasian_College_of_Pharmacy
- https://en.wikipedia.org/wiki/American_Association_of_Colleges_of_Pharmacy
- https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacy
- https://en.wikipedia.org/wiki/American_Pharmacists_Association
- https://www.bio.org/
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Association
- https://en.wikipedia.org/wiki/Canadian_Society_of_Hospital_Pharmacists
- https://en.wikipedia.org/wiki/Chinese_Pharmaceutical_Association
- https://en.wikipedia.org/wiki/American_Association_of_Psychiatric_Pharmacists
- https://en.wikipedia.org/wiki/Danish_Association_of_Pharmaconomists
- https://en.wikipedia.org/wiki/EPhEU
- https://www.fda.gov/
- https://www.gmc-uk.org/
- https://www.ifpma.org/
- https://www.fip.org/
- https://en.wikipedia.org/wiki/International_Pharmaceutical_Students%27_Federation
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://en.wikipedia.org/wiki/National_Pharmacy_Association
- https://en.wikipedia.org/wiki/Norwegian_Pharmacy_Association
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Journal#History
- https://en.wikipedia.org/wiki/Pakistan_Pharmacists_Association
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Mauritius
- https://en.wikipedia.org/wiki/Pharmaceutical_Group_of_the_European_Union
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Australia
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_New_Zealand
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Northern_Ireland
- https://en.wikipedia.org/wiki/Professional_Compounding_Centers_of_America
- https://en.wikipedia.org/wiki/Royal_Pharmaceutical_Society
- https://www.aaps.org/home
- https://www.bioindustry.org/
- https://www.controlledreleasesociety.org/
- https://www.efpia.eu/
- https://www.epemed.org/online/www/content/ENG/index.html
- https://icr-global.org/
- https://ispe.org/
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Israel
- https://www.phrma.org/
- https://en.wikipedia.org/wiki/The_Pharmacy_Guild_of_Australia
- https://en.wikipedia.org/wiki/The_Society_of_Hospital_Pharmacists_of_Australia
- https://en.wikipedia.org/wiki/Healthcare_industry
- https://www.pharma-iq.com/business-development/articles/top-50-pharmaceutical-blogs-and-publications
- https://www.pharmatimes.com/news
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967517/
- https://www.cbo.gov/publication/57126
- http://: https://www.who.int/tools/atc-ddd-toolkit/data
- https://www.oecd.org/els/health-systems/health-data.htm
- https://www.bls.gov/ooh/healthcare/home.htm
- https://data.worldbank.org/topic/8
- https://www.statnews.com/about/
- https://www.health.pa.gov/topics/HealthStatistics/Pages/health-statistics.aspx
- https://www.cdc.gov/nchs/index.htm
- https://www.aha.org/statistics/fast-facts-us-hospitals
- https://www.census.gov/library/publications/2021/demo/p60-274.html
- https://www.adb.org/what-we-do/sectors/health/main
Cancer Immunotherapy Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Product | Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines |
| Application | Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, Ovarian Cancer, Pancreatic Cancer, Others |
| End-Use | Hospital Pharmacy, Retail Pharmacy, Online Pharmacy |
| List of Competitors | Pfizer Inc., AstraZeneca, Merck & Co. Inc, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Novartis AG, Lilly, Johnson & Johnson Services, Inc.; Immunocore Ltd. |
This chapter will help you gain GLOBAL Market Analysis of Cancer Immunotherapy. Further deep in this chapter, you will be able to review Global Cancer Immunotherapy Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Cancer Immunotherapy Revenue Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Cancer Immunotherapy Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Cancer Immunotherapy Revenue Market Size By Region
-
-
1.3 Global Cancer Immunotherapy Market Size By Product 2019 -2031
-
1.3.1 Monoclonal Antibodies Market Size
-
1.3.2 Immunomodulators Market Size
-
1.3.3 Oncolytic Viral Therapies & Cancer Vaccines Market Size
-
-
1.4 Global Cancer Immunotherapy Market Size By Application 2019 -2031
-
1.4.1 Lung Cancer Market Size
-
1.4.2 Breast Cancer Market Size
-
1.4.3 Colorectal Cancer Market Size
-
1.4.4 Melanoma Market Size
-
1.4.5 Prostate Cancer Market Size
-
1.4.6 Head & Neck Cancer Market Size
-
1.4.7 Ovarian Cancer Market Size
-
1.4.8 Pancreatic Cancer Market Size
-
1.4.9 Others Market Size
-
-
1.5 Global Cancer Immunotherapy Market Size By End-Use 2019 -2031
-
1.5.1 Hospital Pharmacy Market Size
-
1.5.2 Retail Pharmacy Market Size
-
1.5.3 Online Pharmacy Market Size
-
-
1.6 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.7 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.7.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.7.2 Global Market Revenue Split By Product
-
1.7.3 Global Market Revenue Split By Application
-
1.7.4 Global Market Revenue Split By End-Use
-
1.7.5 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
This chapter will help you gain North America Market Analysis of Cancer Immunotherapy. Further deep in this chapter, you will be able to review North America Cancer Immunotherapy Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
-
2.1 North America Cancer Immunotherapy Market Size 2019 - 2031
-
2.1.1 North America Cancer Immunotherapy Market Size By Country 2019 - 2031
-
2.1.2 North America Cancer Immunotherapy Market Size by Product 2019 -2031
-
2.1.2.1 North America Monoclonal Antibodies Market Size
-
2.1.2.2 North America Immunomodulators Market Size
-
2.1.2.3 North America Oncolytic Viral Therapies & Cancer Vaccines Market Size
-
-
2.1.3 North America Cancer Immunotherapy Market Size by Application 2019 -2031
-
2.1.3.1 North America Lung Cancer Market Size
-
2.1.3.2 North America Breast Cancer Market Size
-
2.1.3.3 North America Colorectal Cancer Market Size
-
2.1.3.4 North America Melanoma Market Size
-
2.1.3.5 North America Prostate Cancer Market Size
-
2.1.3.6 North America Head & Neck Cancer Market Size
-
2.1.3.7 North America Ovarian Cancer Market Size
-
2.1.3.8 North America Pancreatic Cancer Market Size
-
2.1.3.9 North America Others Market Size
-
-
2.1.4 North America Cancer Immunotherapy Market Size by End-Use 2019 -2031
-
2.1.4.1 North America Hospital Pharmacy Market Size
-
2.1.4.2 North America Retail Pharmacy Market Size
-
2.1.4.3 North America Online Pharmacy Market Size
-
-
This chapter will help you gain Europe Market Analysis of Cancer Immunotherapy. Further deep in this chapter, you will be able to review Europe Cancer Immunotherapy Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
-
3.1 Europe Cancer Immunotherapy Market Size 2019 - 2031
-
3.1.1 Europe Cancer Immunotherapy Market Size By Country 2019 - 2031
-
3.1.2 Europe Cancer Immunotherapy Market Size by Product 2019 -2031
-
3.1.2.1 Europe Monoclonal Antibodies Market Size
-
3.1.2.2 Europe Immunomodulators Market Size
-
3.1.2.3 Europe Oncolytic Viral Therapies & Cancer Vaccines Market Size
-
-
3.1.3 Europe Cancer Immunotherapy Market Size by Application 2019 -2031
-
3.1.3.1 Europe Lung Cancer Market Size
-
3.1.3.2 Europe Breast Cancer Market Size
-
3.1.3.3 Europe Colorectal Cancer Market Size
-
3.1.3.4 Europe Melanoma Market Size
-
3.1.3.5 Europe Prostate Cancer Market Size
-
3.1.3.6 Europe Head & Neck Cancer Market Size
-
3.1.3.7 Europe Ovarian Cancer Market Size
-
3.1.3.8 Europe Pancreatic Cancer Market Size
-
3.1.3.9 Europe Others Market Size
-
-
3.1.4 Europe Cancer Immunotherapy Market Size by End-Use 2019 -2031
-
3.1.4.1 Europe Hospital Pharmacy Market Size
-
3.1.4.2 Europe Retail Pharmacy Market Size
-
3.1.4.3 Europe Online Pharmacy Market Size
-
-
This chapter will help you gain Asia Pacific Market Analysis of Cancer Immunotherapy. Further deep in this chapter, you will be able to review Asia Pacific Cancer Immunotherapy Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Cancer Immunotherapy Market Size 2019 - 2031
-
4.1.1 Asia Pacific Cancer Immunotherapy Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Cancer Immunotherapy Market Size by Product 2019 -2031
-
4.1.2.1 Asia Pacific Monoclonal Antibodies Market Size
-
4.1.2.2 Asia Pacific Immunomodulators Market Size
-
4.1.2.3 Asia Pacific Oncolytic Viral Therapies & Cancer Vaccines Market Size
-
-
4.1.3 Asia Pacific Cancer Immunotherapy Market Size by Application 2019 -2031
-
4.1.3.1 Asia Pacific Lung Cancer Market Size
-
4.1.3.2 Asia Pacific Breast Cancer Market Size
-
4.1.3.3 Asia Pacific Colorectal Cancer Market Size
-
4.1.3.4 Asia Pacific Melanoma Market Size
-
4.1.3.5 Asia Pacific Prostate Cancer Market Size
-
4.1.3.6 Asia Pacific Head & Neck Cancer Market Size
-
4.1.3.7 Asia Pacific Ovarian Cancer Market Size
-
4.1.3.8 Asia Pacific Pancreatic Cancer Market Size
-
4.1.3.9 Asia Pacific Others Market Size
-
-
4.1.4 Asia Pacific Cancer Immunotherapy Market Size by End-Use 2019 -2031
-
4.1.4.1 Asia Pacific Hospital Pharmacy Market Size
-
4.1.4.2 Asia Pacific Retail Pharmacy Market Size
-
4.1.4.3 Asia Pacific Online Pharmacy Market Size
-
-
This chapter will help you gain South America Market Analysis of Cancer Immunotherapy. Further deep in this chapter, you will be able to review South America Cancer Immunotherapy Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
-
5.1 South America Cancer Immunotherapy Market Size 2019 - 2031
-
5.1.1 South America Cancer Immunotherapy Market Size By Country 2019 - 2031
-
5.1.2 South America Cancer Immunotherapy Market Size by Product 2019 -2031
-
5.1.2.1 South America Monoclonal Antibodies Market Size
-
5.1.2.2 South America Immunomodulators Market Size
-
5.1.2.3 South America Oncolytic Viral Therapies & Cancer Vaccines Market Size
-
-
5.1.3 South America Cancer Immunotherapy Market Size by Application 2019 -2031
-
5.1.3.1 South America Lung Cancer Market Size
-
5.1.3.2 South America Breast Cancer Market Size
-
5.1.3.3 South America Colorectal Cancer Market Size
-
5.1.3.4 South America Melanoma Market Size
-
5.1.3.5 South America Prostate Cancer Market Size
-
5.1.3.6 South America Head & Neck Cancer Market Size
-
5.1.3.7 South America Ovarian Cancer Market Size
-
5.1.3.8 South America Pancreatic Cancer Market Size
-
5.1.3.9 South America Others Market Size
-
-
5.1.4 South America Cancer Immunotherapy Market Size by End-Use 2019 -2031
-
5.1.4.1 South America Hospital Pharmacy Market Size
-
5.1.4.2 South America Retail Pharmacy Market Size
-
5.1.4.3 South America Online Pharmacy Market Size
-
-
This chapter will help you gain Middle East and Africa Market Analysis of Cancer Immunotherapy. Further deep in this chapter, you will be able to review Middle East and Africa Cancer Immunotherapy Market Split by various segments and Country Split.
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Cancer Immunotherapy Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Cancer Immunotherapy Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Cancer Immunotherapy Market Size by Product 2019 -2031
-
6.1.2.1 Middle East and Africa Monoclonal Antibodies Market Size
-
6.1.2.2 Middle East and Africa Immunomodulators Market Size
-
6.1.2.3 Middle East and Africa Oncolytic Viral Therapies & Cancer Vaccines Market Size
-
-
6.1.3 Middle East and Africa Cancer Immunotherapy Market Size by Application 2019 -2031
-
6.1.3.1 Middle East and Africa Lung Cancer Market Size
-
6.1.3.2 Middle East and Africa Breast Cancer Market Size
-
6.1.3.3 Middle East and Africa Colorectal Cancer Market Size
-
6.1.3.4 Middle East and Africa Melanoma Market Size
-
6.1.3.5 Middle East and Africa Prostate Cancer Market Size
-
6.1.3.6 Middle East and Africa Head & Neck Cancer Market Size
-
6.1.3.7 Middle East and Africa Ovarian Cancer Market Size
-
6.1.3.8 Middle East and Africa Pancreatic Cancer Market Size
-
6.1.3.9 Middle East and Africa Others Market Size
-
-
6.1.4 Middle East and Africa Cancer Immunotherapy Market Size by End-Use 2019 -2031
-
6.1.4.1 Middle East and Africa Hospital Pharmacy Market Size
-
6.1.4.2 Middle East and Africa Retail Pharmacy Market Size
-
6.1.4.3 Middle East and Africa Online Pharmacy Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Cancer Immunotherapy Market Size by Product 2019 -2031
-
7.1.2 Country 1Cancer Immunotherapy Market Size by Application 2019 -2031
-
7.1.3 Country 1Cancer Immunotherapy Market Size by End-Use 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
This chapter provides an in-depth analysis of the market share among key competitors of Cancer Immunotherapy. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Cancer Immunotherapy Market Revenue and Share by Key Players
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Pfizer Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 AstraZeneca
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Merck & Co. Inc
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 F. Hoffmann-La Roche Ltd
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Bristol-Myers Squibb Company
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Novartis AG
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Lilly
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Johnson & Johnson Services
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Inc.; Immunocore Ltd.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Restraints
-
9.3 Market Trends
-
9.4 Market Opportunity
-
9.5 Technological Road Map (Subject to Data Availability)
-
9.6 Product Life Cycle (Subject to Data Availability)
-
9.7 Consumer Preference Analysis
-
9.8 Market Attractiveness Analysis
-
9.9 PESTEL Analysis
-
9.9.1 Political Factors
-
9.9.2 Economic Factors
-
9.9.3 Social Factors
-
9.9.4 Technological Factors
-
9.9.5 Legal Factors
-
9.9.6 Environmental Factors
-
-
9.10 Industrial Chain Analysis (Subject to Data Availability)
-
9.10.1 Industry Chain Analysis
-
9.10.2 Manufacturing Cost Analysis
-
9.10.3 Supply Side Analysis
-
9.10.3.1 Raw Material Analysis
-
9.10.3.2 Raw Material Procurement Analysis
-
9.10.3.3 Raw Material Price Trend Analysis
-
-
-
9.11 Porter’s Five Forces Analysis
-
9.11.1 Bargaining Power of Suppliers
-
9.11.2 Bargaining Power of Buyers
-
9.11.3 Threat of New Entrants
-
9.11.4 Threat of Substitutes
-
9.11.5 Degree of Competition
-
-
9.12 Patent Analysis (Subject to Data Availability)
-
9.13 ESG Analysis
Segmentation Product Analysis 2019 -2031, will provide market size split by Product. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Product Analysis 2019 -2031
-
10.1 Monoclonal Antibodies
-
10.1.1 Global Cancer Immunotherapy Revenue Market Size and Share by Monoclonal Antibodies 2019 -2031
-
-
10.2 Immunomodulators
-
10.2.1 Global Cancer Immunotherapy Revenue Market Size and Share by Immunomodulators 2019 -2031
-
-
10.3 Oncolytic Viral Therapies & Cancer Vaccines
-
10.3.1 Global Cancer Immunotherapy Revenue Market Size and Share by Oncolytic Viral Therapies & Cancer Vaccines 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2019 -2031
-
11.1 Lung Cancer
-
11.1.1 Global Cancer Immunotherapy Revenue Market Size and Share by Lung Cancer 2019 - 2031
-
-
11.2 Breast Cancer
-
11.2.1 Global Cancer Immunotherapy Revenue Market Size and Share by Breast Cancer 2019 - 2031
-
-
11.3 Colorectal Cancer
-
11.3.1 Global Cancer Immunotherapy Revenue Market Size and Share by Colorectal Cancer 2019 - 2031
-
-
11.4 Melanoma
-
11.4.1 Global Cancer Immunotherapy Revenue Market Size and Share by Melanoma 2019 - 2031
-
-
11.5 Prostate Cancer
-
11.5.1 Global Cancer Immunotherapy Revenue Market Size and Share by Prostate Cancer 2019 - 2031
-
-
11.6 Head & Neck Cancer
-
11.6.1 Global Cancer Immunotherapy Revenue Market Size and Share by Head & Neck Cancer 2019 - 2031
-
-
11.7 Ovarian Cancer
-
11.7.1 Global Cancer Immunotherapy Revenue Market Size and Share by Ovarian Cancer 2019 - 2031
-
-
11.8 Pancreatic Cancer
-
11.8.1 Global Cancer Immunotherapy Revenue Market Size and Share by Pancreatic Cancer 2019 - 2031
-
-
11.9 Others
-
11.9.1 Global Cancer Immunotherapy Revenue Market Size and Share by Others 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by End-Use Analysis 2019 -2031
-
12.1 Hospital Pharmacy
-
12.1.1 Global Cancer Immunotherapy Revenue Market Size and Share by Hospital Pharmacy 2019 -2031
-
-
12.2 Retail Pharmacy
-
12.2.1 Global Cancer Immunotherapy Revenue Market Size and Share by Retail Pharmacy 2019 -2031
-
-
12.3 Online Pharmacy
-
12.3.1 Global Cancer Immunotherapy Revenue Market Size and Share by Online Pharmacy 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Cancer Immunotherapy market
Chapter 13 Research Findings
-
13.1 Key Takeaways
-
13.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
13.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Manjiri Kanhere and Team
- 1.1 Cancer Immunotherapy Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Cancer Immunotherapy Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Cancer Immunotherapy Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Cancer Immunotherapy Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Cancer Immunotherapy Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Cancer Immunotherapy Market
Key Questions Answered By Cancer Immunotherapy Market Report 2024
| Why Monoclonal Antibodies have a significant impact on Cancer Immunotherapy market? |
| What are the key factors affecting the Monoclonal Antibodies and Immunomodulators of Cancer Immunotherapy Market? |
| What is the CAGR/Growth Rate of Lung Cancer during the forecast period? |
| By type, which segment accounted for largest share of the global Cancer Immunotherapy Market? |
| Which region is expected to dominate the global Cancer Immunotherapy Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
